Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    "Hyperlipoproteinemia type 3"
Show Display Options
RSS Create an RSS feed from your search for:
"Hyperlipoproteinemia type 3"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting DARK STUDY "DysbetalipoproteinemiA and atheRoma Risk"
Condition: Dysbetalipoproteinemia
Intervention:
2 Completed Type III Dysbetalipoproteinemia
Condition: Hyperlipoproteinemia Type III
Interventions: Drug: Rosuvastatin;   Drug: rosuvastatin;   Drug: pravastatin
3 Terminated Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.
Condition: Hyperlipoproteinemia Type III
Interventions: Drug: torcetrapib/atorvastatin;   Drug: atorvastatin;   Drug: fenofibrate

Indicates status has not been verified in more than two years